You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
25 August 2026 - Healthcare services company McKesson Corporation (NYSE:MCK) announced on Tuesday that it has signed a definitive agreement to acquire Precision Medicine Group, a global provider of clinical research and biopharma commercialisation se...
25 August 2026 - Personalised cancer immunotherapy company BreakBio Corp announced on Monday that it is entering the clinic next quarter.BreakBio says it is designed for higher efficacy than Moderna's individualised neoantigen therapy (INT). For...
25 August 2026 - Healthcare products company Johnson & Johnson (NYSE:JNJ) announced on Monday that the US Food and Drug Administration (FDA) has approved IMAAVY (nipocalimab-aahu) for the treatment of warm autoimmune haemolytic anaemia (wAIHA), a...
25 August 2026 - Japanese pharmaceutical company Astellas Pharma Inc (TSE:4503) announced on Monday that the first patient has been dosed in a Phase 3 study evaluating ASP2138 in combination with chemotherapy and pembrolizumab as first-line treatment...
25 August 2026 - Commercial-stage biotech company Antengene Corporation Limited (SEHK:6996.HK) announced on Monday that the Phase I ATTRACT study of its proprietary ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody for B cell-related autoi...
24 August 2026 - Medical technology company Tempus AI Inc (NASDAQ: TEM) reported on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, an AI-enabled software device designed to analyse standard ...
24 August 2026 - US biopharmaceutical company Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), said on Monday it has received European Commission orphan designation for imsidolimab, its investigational monoclonal antibody for Generalised Pustular Psoriasis...